A major challenge associated with the determination of the unbound brain-to-plasma concentration ratio of a drug (K p,uu,brain ), is the error associated with correction for the drug in various vascular spaces of the brain, i.e., in residual blood. The apparent brain vascular spaces of plasma water (V water , 10.3 lL/g brain), plasma proteins (V protein , 7.99 lL/g brain), and the volume of erythrocytes (V er , 2.13 lL/g brain) were determined and incorporated into a novel, drug-specific correction model that took the drug-unbound fraction in the plasma (f u,p ) into account. The correction model was successfully applied for the determination of K p,uu,brain for indomethacin, loperamide, and moxalactam, which had potential problems associated with correction. The influence on correction of the drug associated with erythrocytes was shown to be minimal. Therefore, it is proposed that correction for residual blood can be performed using an effective plasma space in the brain (V eff ), which is calculated from the measured f u,p of the particular drug as well as from the estimates of V water and V protein , which are provided in this study. Furthermore, the results highlight the value of determining K p,uu,brain with statistical precision to enable appropriate interpretation of brain exposure for drugs that appear to be restricted to the brain vascular spaces.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.